PrescriptionDrugs.org

What to Expect When Starting Zolpidem

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Zolpidem (brand names Ambien, Ambien CR, Edluar, Intermezzo) is a non-benzodiazepine sedative-hypnotic that selectively binds to the alpha-1 subunit of the GABA-A receptor complex, inducing sleep without the broader CNS depressant effects of traditional benzodiazepines [1]. It is approved for the short-term treatment of insomnia characterized by difficulty with sleep initiation [2]. Zolpidem has a rapid onset (15-30 minutes) and short half-life (2-3 hours for immediate-release), making it effective for sleep onset while minimizing next-morning grogginess — though residual effects can still occur, particularly in women and elderly patients.

Week-by-week timeline

First NightOnly take zolpidem when you can immediately go to bed and remain in bed for 7-8 hours. Taking it and staying awake increases the risk of bizarre sleep-related behaviors.

Initial Use

Take 5 mg (women) or 5-10 mg (men) immediately before bedtime, only when you can dedicate 7-8 hours to sleep [1]. Zolpidem reaches peak blood levels in 1.6 hours and induces sleep within 15-30 minutes in most patients. The FDA recommends lower starting doses for women because they metabolize zolpidem more slowly, resulting in higher morning blood levels [1]. Common first-use effects include rapid sleep onset, occasional vivid dreams, and possible grogginess upon waking, especially if sleep duration is less than 7 hours.

First WeekIf you experience any activities during sleep that you do not remember (eating, walking, making phone calls), discontinue zolpidem and contact your doctor immediately.

Establishing Your Response

Over the first few days, you will learn how zolpidem affects you individually. Common side effects include daytime drowsiness (2-5%), dizziness (5%), headache (7%), and GI effects (nausea, diarrhea) [1][2]. Next-morning impairment — especially in driving — is a documented risk, particularly at the 10 mg dose and in women. The FDA issued a 2013 safety warning specifically about this [1]. Complex sleep behaviors (sleepwalking, sleep-eating, sleep-driving) occur rarely but are a serious concern.

Week 2-4Zolpidem is classified as a Schedule IV controlled substance due to abuse and dependence potential. Follow the prescribed duration closely.

Short-Term Treatment Assessment

Zolpidem is intended for short-term use (typically 7-10 days, up to 2-4 weeks with reassessment) [1]. By week 2, assess whether your insomnia has improved and whether the underlying cause has been addressed. Tolerance can develop relatively quickly with nightly use, leading some patients to feel the medication is less effective [2]. Physical dependence can begin developing within 2 weeks of nightly use, making it important to have a plan for discontinuation or intermittent use.

Beyond 4 WeeksCognitive behavioral therapy for insomnia (CBT-I) is considered first-line treatment and is more effective long-term than medication. Discuss this option with your doctor.

Reassessment and Potential Discontinuation

If insomnia persists beyond 2-4 weeks, your doctor should reassess for underlying causes (sleep apnea, depression, anxiety, poor sleep hygiene, medication effects) rather than simply continuing zolpidem [1]. Long-term use is associated with tolerance, dependence, rebound insomnia upon discontinuation, and increased fall risk in elderly patients [2]. If discontinuing after more than a few weeks of nightly use, gradual tapering may be needed to prevent rebound insomnia and withdrawal symptoms (anxiety, insomnia, tremor).

When to call your doctor

Contact your healthcare provider if you experience:

  • Complex sleep behaviors: sleepwalking, sleep-driving, sleep-eating, or other activities performed while not fully awake that you do not remember — discontinue immediately and seek medical advice [1]
  • Severe allergic reactions: swelling of face/tongue/throat, difficulty breathing, nausea/vomiting — anaphylaxis has been reported [1]
  • Significant next-morning impairment: feeling drugged, very drowsy, or unable to function — do not drive or operate machinery [1]
  • Suicidal thoughts, worsening depression, unusual agitation, or hallucinations [1]
  • Signs of dependence: needing higher doses for the same effect, feeling unable to sleep without it, anxiety when a dose is missed [2]
  • Falls, especially in elderly patients — zolpidem significantly increases fall risk during nighttime awakenings [1]

Tips for getting started

Take zolpidem immediately before getting into bed — do not take it and then stay up doing activities, as this increases the risk of amnesia and bizarre behavior [1]. Only take it when you can commit to 7-8 hours of sleep. Do not take with or shortly after a heavy meal, as food delays absorption. Avoid alcohol completely while using zolpidem — the combination dramatically increases sedation and the risk of complex sleep behaviors [1]. Start at the lowest effective dose (5 mg), especially if you are female, elderly, or taking other CNS depressants [1]. Keep the medication in a secure place and do not share it — it is a controlled substance. Consider using zolpidem intermittently (3-4 nights per week) rather than nightly to reduce tolerance and dependence risk [2].

Frequently asked questions

More about Zolpidem

References

  1. [Regulatory] Ambien (zolpidem) FDA Prescribing Information. Sanofi-Aventis. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019908s039lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Zolpidem. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK442008/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: